Tyra Biosciences stockholders elect three Class I directors and ratify Ernst & Young as auditor at 2022 Annual Meeting

Tyra Biosciences, Inc.

Todd Harris, Nina Kjellson, and Siddarth Subramony elected as Class I directors with ~30.05M votes each; broker non-votes ~1.09M.
Ratification of Ernst & Young as independent auditor for FY2022 approved with 31,551,343 votes for, 0 against, 927 abstentions.
Meeting held on June 13, 2022; all director nominees and auditor ratification passed without opposition.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.